Video
23 Oct 2024
Development and Manufacturing of New APIs: Leveraging Experience, Technological Innovation, and Present Vision to Future Success.
-file151657.png)
In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences.
Content provided by our supplier
Dipharma
-
IT -
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Other Content from Dipharma (3)
-
News Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process. The Company expands its range of CGMP services to include small-scale commercial APIs. -
News Dipharma expands its Italian R&D Center to increase its analytical services
The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.
-
Video The Dipharma Group - Experience you can trust
The Dipharma Group is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering APIs with DMFs registered worldwide.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance